Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1

NCT: NCT02777528 · ACTIVE_NOT_RECRUITING

NCT IDNCT02777528
StatusACTIVE_NOT_RECRUITING
Start Date2016-08
Completion2028-03
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.

Frequently Asked Questions

What is Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1?

Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 is a clinical trial registered under NCT02777528. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02777528?

The current status of NCT02777528 (Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1) is: ACTIVE_NOT_RECRUITING.

When did Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 start?

Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 started on 2016-08.

Related Devices

PMA P230023Endovascular system for treatment of thoracoabdominal and pararenal aortic lesionsW. L. Gore & Associates, Inc. K170740GORE VIABIL Short Wire Biliary EndoprosthesisW. L. Gore & Associates, Inc. PMA P020004SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTW. L. Gore & Associates, Inc. PMA P040043SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTW. L. Gore & Associates, Inc. PMA P210032SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTW. L. Gore & Associates, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑